The founding story of DoctorOnTap is not unusual in the way startup origin stories go — a personal frustration, a gap identified, a solution built. What makes it worth paying attention to is the scale of the gap it is trying to close and the speed at which it is moving to close it.
Paul Oisamoje, co-founder and CEO, traces the idea directly to a personal experience with delayed diagnosis of a serious illness. The encounter with a healthcare system that moves too slowly for people whose lives move too fast crystallised something he had already been observing professionally — through years working in healthcare financing, where the distance between Nigerians and quality medical care was not just a logistical problem but a systemic one.
Launched in December 2025 and registered simultaneously in Nigeria, the United States, and Rwanda, DoctorOnTap offers virtual doctor consultations, second-opinion services, vetted caregiver placement, and coordination of international medical treatment. The multi-country registration from day one signals an intention that goes beyond building a Nigerian telemedicine app — it signals a continental play structured from the start for cross-border operation.
That ambition is already producing results. The platform has secured a provisional operational licence from Rwanda’s Ministry of Health, marking its first formal regulatory foothold outside Nigeria and opening a path into East Africa’s growing digital health market.
The target user the platform is built around is specific and deliberately chosen: the busy professional. Nigeria’s working population sits at the intersection of two compounding problems — high healthcare need and chronically low time availability to address it. Demanding work schedules, long commutes, and the practical difficulty of accessing quality care during working hours mean that health concerns are routinely deferred until they become emergencies. DoctorOnTap’s model is built on the premise that this deferral is not inevitable — it is an infrastructure problem with a digital solution.
“Our platform is designed to ensure that individuals do not have to choose between their professional responsibilities and their wellbeing,” Oisamoje said in an interview with Voice of Nigeria.
But the platform’s ambition extends well beyond urban professionals with smartphones and stable internet connections. To reach rural and underserved communities — where the healthcare access gap is deepest — DoctorOnTap is exploring integration with WhatsApp, a platform with near-ubiquitous penetration across Nigeria’s income spectrum. If executed well, that integration could meaningfully expand who the platform serves, moving it from a premium service for connected professionals toward something closer to its stated mission of universal access.
The internal structure reflects the breadth of that mission. Clinical services are led by Dr. Habibah Abare, while pharmaceutical services are co-founded by Omo Kabwa — a team composition that suggests the platform is being built as a genuine healthcare ecosystem rather than a consultation booking interface with a medical veneer.
Oisamoje’s language around the long-term vision is explicit: “We are building a system that goes beyond virtual consultations. Our goal is to create a hospital without walls — a fully integrated platform where users can access a range of healthcare services seamlessly.”
The telemedicine sector in Nigeria is growing, and DoctorOnTap is entering a market that already has players. What distinguishes its positioning is the combination of multi-country registration, early regulatory traction in Rwanda, diaspora focus, and the ambition to integrate services — consultations, second opinions, caregiving, and international treatment coordination — into a single platform rather than a single service.
Whether the hospital without walls becomes a reality depends on execution, funding, and regulatory navigation across multiple jurisdictions. But the foundation — a clear problem, a specific user, a multi-market registration, and an early licence in a key growth market — is more solid than most health startups launch with.
The delayed diagnosis that inspired it may have cost time. The platform built in response is clearly not interested in wasting any more.
